A structural overview of G-protein-coupled receptors in neurological disorders
- 29 January 2026
- journal article
- review article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 47 (5) , 1077-1102
Abstract
Neuropsychiatry and neurodegenerative disorders (NPDs and NDDs) are often associated with various physiological factors. It is increasingly apparent that signal transducers like G-protein-coupled receptors (GPCRs) are critical in disease progression and constitute an important class of drug targets. Several members of class A, class B, and class C GPCR families, along with their cognate binding partners, are involved in neurotransmission and neuromodulation. The vast information about the different molecular states of these GPCRs with their signaling complexes unravels the understanding of residual specificity in these protein-protein interactions and the dynamicity of transmembrane helices. The atypical mode of interaction of GPCRs with binding partners provides valuable insights for GPCR-conformation-based drug designing. In this review, we highlight the structural features of the serotonin, dopamine, and corticotropin receptors, namely 5-HTR1A, 5-HTR1B, 5-HTR2A, 5-HTR2B, 5-HTR2C, 5-HTR4, 5-HTR6, 5-HTR7, D1-5R, and CRF1-2R when forming transient complexes with G-proteins and arrestins. The distinct structural characteristics of these receptors explain the underlying molecular mechanism for signaling specificity and related physiological processes. This review also summarizes the importance of these structural insights in developing newer and effective pharmacologically biased drugs that can mediate specific signaling pathways to GPCRs.Keywords
This publication has 220 references indexed in Scilit:
- Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptorsJournal of Neural Transmission, 2025
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Structural biology of G protein‐coupled receptor signaling complexesProtein Science, 2018
- The 5-HT1B receptor - a potential target for antidepressant treatmentPsychopharmacology, 2018
- Serotonin (5-HT) receptor 2b activation augments glucose-stimulated insulin secretion in human and mouse islets of LangerhansDiabetologia, 2016
- Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's diseaseMovement Disorders, 2011
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Serotonin 2A Receptors and Visual Hallucinations in Parkinson DiseaseArchives of Neurology, 2010
- Duloxetine in treatment of anxiety symptoms associated with depressionDepression and Anxiety, 2003
- Indirect in vivo 5-HT 1A -agonistic effects of the new antidepressant mirtazapinePsychopharmacology, 1997